佛山职业技术学院财务处

暂无描述...

纳米与界面催化研究组

暂无描述...

天鹅铝业有限公司

天鹅铝业有限公司天鹅铝业有限公司是天鹅集团公司投资10亿元兴建的,是集铝合金研发、生产与销售等为一体的综合性铝型材企业。公司占地面积30万平方米，年产优质铝型材20万吨。主要生产各种建筑类、装饰类、工业类、军工类和特种铝合金型材等产品。

沈阳地铁

暂无描述...

上海栢敖思检测技术有限公司,在线红外测温仪,气体质量流量计,热式气体质量流量计,质量流量标定系统,质量流量计,热式质量流量计,气体流量计 - 上海栢敖思检测技术有限公司

上海栢敖思检测技术有限公司是一家专业经营高品质温度、压力、流量检测仪器的研发与销售的高科技公司。主要产品:在线红外测温仪,气体质量流量计,热式气体质量流量计,质量流量标定系统,质量流量计,热式质量流量计,气体流量计

福建省泰云春茶业有限公司|福建省泰云春茶业|泰云春茶业【官网】

福建省泰云春茶业有限公司起源于1962年铁山人民公社茶场，1979年，福建政和吴氏后人创立吴家山茶厂，2008年，政和白茶制作技艺非物质文化传承人——吴碧海先生注册为福建省泰云春茶业有限公司。公司位于全国产茶明星县——福建省政和县，是一家集生态茶园研发、生产、销售、仓储及茶文化传播为一体的农业产业化省级龙头企业。主要生产“政和白茶”系列——白毫银针、白牡丹、贡眉、寿眉。

危化品泄漏应急处置措施-危化品应急网

危化品应急预案6个步骤,危化品应急预案演练多久一次?危化品应急预案报哪里备案?危化品应急预案方案,危化品应急演练方案,危化品应急演练图片,危化品应急管理制度,危化品应急处理措施,危化品泄漏应急处置措施就找危化品应急网。

青橙智慧校园

暂无描述...

WestVac Biopharma

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.